col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


175 Results       Page 1

 [1] 
Elsevier: Biochemical and Biophysical Research Communications
  original article Date Title Authors   All Authors
1 [GO] 2026―Jul―21 Convergent Genetic and Structural Parameters of Cardiovascular Disease Related Insights of Post-Acute COVID-19 Rajas M. Rao, Narendra Kumar, Shaminth Prasad P, Manvitha J. Rao, Farooq Hussain P, Chaitanya Shree N S, et al. (+4)
2 [GO] 2026―Jul―16 C5a-C5aR1 axis activation drives neutrophil extracellular trap formation in SARS-CoV-2 N protein-mediated acute kidney injury Cuilan Liu, Ziyi Yan, Ziyi Tao, Wen Yang, Xiaoli Han, Linlin Wang, Shengjun Liu
3 [GO] 2026―Jun―04 Targeting the Conserved RNA-Dependent RNA Polymerase with Antisense Oligonucleotides Suppresses SARS-CoV-2 Variants Rui Su, Letian Li, Jingyi Gu, Rongjun Xu, Yiling Long, Wenjing Shi, et al. (+5)
4 [GO] 2026―Apr―03 Integrative network pharmacology and molecular simulation analysis reveals the therapeutic potential of Coscinium fenestratum alkaloids against SARS-CoV-2 P. Sakthi, K. Arun, D. Priya
5 [GO] 2026―Jan―24 Bioengineered Chimeric VLPs Targeting Chikungunya Virus and SARS-CoV-2 Show High Immunogenicity in Mice Vedita Anand Singh, Sanketkumar Nehul, Ankita Saha, Vishakha Singh, Mandar Bhutkar, Chandra Shekhar Kumar, et al. (+5)
6 [GO] 2026―Jan―12 Single-cell RNA sequencing data analysis reveals differential expressions of ion channels in immunity response to pulmonary COVID-19 infection Xin Wu, Vishwa Bhatt, Jianhua J. Liu, Liang Hong
7 [GO] 2025―Dec―20 Leveraging Genomic Conservation in Emerging SARS-CoV-2 Variants for Precision Diagnostics, Vaccines, and RNAi Therapeutics Cuneyd Parlayan, Khandakar A.S.M. Saadat, Muhammetnur Tekayev, Shekufe Rezghi Barez
8 [GO] 2025―Nov―20 Helix α1 of human ACE2 mimics dsDNA and Spike of SARS-CoV-2 binds DNA Madhavi Latha Yadav Bangaru, Nidhanapati K. Raghavendra
9 [GO] 2025―Nov―08 mRNA Vaccines for Porcine Reproductive and Respiratory Syndrome: A New Paradigm in Swine Health Mirwaise Khan, Osamu Taira, Xinqi Shi, Haiwei Wang, Xuehui Cai
10 [GO] 2025―Nov―07 Innovations and Challenges in Vaccine Development: Lessons from the SARS-CoV-2 pandemic and Prospects Ahmed Mohammed, Nasir A. Ibrahim, Nosiba S. Basher
11 [GO] 2025―Jul―01 Ionic liquids and lysosomotropic detergents as inhibitors of the SARS-CoV-2 main protease: QSAR modeling, synthesis and biological testing Diana Hodyna, Anastasiia Gryniukova, Sergiy Rogalsky, Petro Borysko, Vasyl Kovalishyn, Larysa Metelytsia
12 [GO] 2025―Jun―21 Papain-like protease of SARS-CoV-2 inhibits dsRNA-induced type I interferon response partly by cleaving TBK1 Wei-Hua Zheng, Run-Ze Ni, Xiang-Hong Ran, Dan Mu
13 [GO] 2025―Jun―06 Nanobody-based fluorescent immunoassay for SARS-CoV-2 spike detection via site-specific microbial transglutaminase labeling Zhiran Fan, Jing Li, Liu He, Qianying Li, Shenglan Zhang
14 [GO] 2025―Apr―30 High-resolution structure reveals enhanced 14-3-3 binding by a mutant SARS-CoV-2 nucleoprotein variant with improved replicative fitness Kristina V. Perfilova, Ilya O. Matyuta, Mikhail E. Minyaev, Konstantin M. Boyko, Richard B. Cooley, Nikolai N. Sluchanko
15 [GO] 2025―Apr―17 Role of membrane proximal actin regulators in SARS-CoV-2 spike-induced cell-cell fusion Linting Kou, Yumeng Wan, Yuri L. Nemoto, Kazuya Tsujita, Toshiki Itoh
16 [GO] 2025―Apr―15 SARS-CoV-2 NSP2 specifically interacts with cellular protein SmgGDS Xiaoyu Chu, Yixuan Yang, Hangtian Guo, Xiaoyun Ji
17 [GO] 2025―Apr―14 Structural and functional insights into the SARS-CoV-2 SUD domain and its interaction with RNA G-Quadruplexes Yu-Hang Zhang, Ai-Min Su, Xi-Miao Hou
18 [GO] 2025―Mar―18 A novel replicase-mediated self-amplifying RNA amplification mechanism of the SARS-CoV-2 replication-transcription system Hsien-Lin Liu, Sam Lin, William Hung, Donald C. Chang, Shi-Lung Lin
19 [GO] 2025―Mar―06 Targeting the liquid-liquid phase separation of nucleocapsid broadly inhibits the replication of SARS-CoV-2 strains Lin Gu, Zheng-Jie Wang, Xin-Ran Zhang, Yu Liu, Ming Zhao, Shao-Zhen Jiang, et al. (+7)
20 [GO] 2025―Feb―27 Structure and Dynamics of Alpha B.1.1.7 SARS-CoV-2 S-Protein in complex with Fab of neutralizing antibody REGN10987 Milita V. Kocharovskaya, Evgeny B. Pichkur, Artem D. Ivannikov, Daria D. Kharlampieva, Ekaterina N. Grafskaia, Ekaterina N. Lyukmanova, et al. (+2)
21 [GO] 2025―Feb―14 Novel Nanobody Drug Conjugate as a Prophylactic or Therapeutic against SARS-CoV-2 infection in mice Brian Imbiakha, Shahrzad Ezzatpour, David W. Buchholz, Suresh Poosala, Bharadwaja Vadloori, Akshay Sonawane, et al. (+14)
22 [GO] 2024―Dec―25 Engineering mRNA Vaccine with Broad-Spectrum Protection Against SARS-CoV-2 Variants Shuang Du, Liu Yang, Xingguang Chen, Yonghao Chen, Liang Weng, Hui Huang, Silin Pang
23 [GO] 2024―Nov―26 Digital reverse transcription PCR using a simple poly(dimethylsiloxane) microwell array chip for detection of SARS-CoV-2 Kazuo Hosokawa, Hitoshi Ohmori
24 [GO] 2024―Nov―04 Exploring B-cell Epitope Conservation and Antigenicity Shift in Current COVID-19 Variants: Analyzing Spike-Antibody Interactions for Therapeutic Uses Alankar Roy, Ishani Paul, Tanwi Paul, Aritrika Dihidar, Sujay Ray
25 [GO] 2024―Oct―20 Protein mimics of fusion core from SARS-CoV-1 can inhibit SARS-CoV-2 entry Yancheng Zhan, Moxuan Li, Rui Gong
26 [GO] 2024―Sep―26 Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody Vishakha Singh, Mandar Bhutkar, Shweta Choudhary, Sanketkumar Nehul, Rajesh Kumar, Jitin Singla, et al. (+2)
27 [GO] 2024―Aug―29 Leveraging the potential of bacterial lateral gene transfer in boosting the efficacy of an edible probiotic prototype yogurt vaccine for COVID-19 Madhuri Vissapragada, Santhinissi Addala, Madhumita Aggunna, Manikanta Sodasani, Abhinav V.K.S. Grandhi, Ravikiran S. Yedidi
28 [GO] 2024―Aug―23 A SARS-CoV-2 peptide antigen purified from bacteria and displayed in a high-density repetitive manner on a virus-like particle could generate anti-SARS-CoV-2 neutralizing antibodies unlike free peptide Feroza Begum, Shreyashi Chandra, Md Hasan Mallik, Jhilik Dey, Prem Prakash Tripathi, Upasana Ray
29 [GO] 2024―Jul―29 Structural basis of main proteases of MERS-CoV bound to antineoplastic drug carmofur Li Guo, Pei Zeng, Xuelan Zhou, Wenwen Li, Jin Zhang, Jian Li
30 [GO] 2024―Jun―06 Structural basis of rosmarinic acid inhibitory mechanism on SARS-CoV-2 main protease Qianhui Li, Xuelan Zhou, Weiwei Wang, Qin Xu, Qisheng Wang, Jian Li
31 [GO] 2024―May―19 Signal peptide replacement of Ag43 enables an efficient bacterial cell surface display of Receptor-Binding Domain of Coronavirus Xuyan Zhang, Youcai Qin, Xiaochen Han, Qingrong Li, Zhe Wang, Xingyuan Wang, et al. (+6)
32 [GO] 2024―May―14 Mutations in the SARS-CoV-2 Spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants. Kouichi Tachibana, Yoshihiko Nakamura, Thi Ly Do, Takanori Kihara, Hiroshi Kawada, Norio Yamamoto, Kiyoshi Ando
33 [GO] 2024―May―08 A Cell Based Assay Using Virus-like Particles to Screen AM Type Mimics for SARS-CoV-2 Neutralisation Neeraj Kailash Gaur, Shreegauri Urankar, Durba Sengupta, V. Ramana Chepuri, Ravindra D. Makde, Kiran Kulkarni
34 [GO] 2024―Apr―23 Collection and transportation of SARS-CoV-2 and influenza A virus diagnostic samples: Optimizing the usage of guanidine-based chaotropic salts for enhanced biosafety and viral genome preservation James G. Komu, Dulamjav Jamsransuren, Sachiko Matsuda, Haruko Ogawa, Yohei Takeda
35 [GO] 2024―Apr―16 Computational investigation of the inhibitory interaction of IRF3 and SARS-CoV-2 accessory protein ORF3b Ganggang Bai, Xincheng Zeng, Linghao Zhang, Yanjing Wang, Buyong Ma
36 [GO] 2024―Apr―16 Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells Magdalena Kulma, Aleksandra Šakanović, Apolonija Bedina-Zavec, Simon Caserman, Neža Omersa, Gašper Šolinc, et al. (+11)
37 [GO] 2024―Mar―25 Agonists or positive allosteric modulators of α7 nicotinic acetylcholine receptor prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells Olena Kalashnyk, Olena Lykhmus, Raymond Sullivan, Serhiy Komisarenko, Maryna Skok
38 [GO] 2024―Mar―23 Polylevodopa nanoplatform for lateral flow immunochromatography assay of SARS-CoV-2 and influenza A virus Kangsong He, Yabing Ye, Shang Liu, Pengcheng Yuan, Wenjing Sun, Jianbin Tang
39 [GO] 2024―Mar―11 Influence of storage solution, temperature, assay time and concentration on RT-qPCR nucleic acid detection for SARS-CoV-2 detection of SARS-CoV-2 by the RT-qPCR Lingxuan Su, Yihan Lou, Jiaxuan Li, Haiyan Mao, Jianhua Li, Yi Sun, et al. (+5)
40 [GO] 2023―Dec―16 Rapid and high throughput assessment of cellular immunity against SARS-CoV-2 based on the ex vivo activation of genes in leukocyte assay with whole blood Taro Saito, Arnaud Couzinet, Taku Murakami, Manami Shimomura, Toshihiro Suzuki, Yuki Katayama, Tetsuya Nakatsura
41 [GO] 2023―Dec―03 Crystal structure of SARS-CoV-2 main protease (Mpro) mutants in complex with the non-covalent inhibitor CCF0058981 Haihai Jiang, Xiaofang Zou, Xuelan Zhou, Jin Zhang, Jian Li
42 [GO] 2023―Oct―14 Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal transition in COVID-19 lung fibrosis Lanlan Zhang, Xin Zhang, Xiaoqian Deng, Pengbo Wang, Yan Mo, Yuansheng Zhang, Xia Tong
43 [GO] 2023―Aug―31 The basis of complications in the context of SARS-CoV-2 infection: Pathological activation of ADAM17 Shenghai Jiang, Hao Yang, Zhongming Sun, Yi Zhang, Yan Li, Jida Li
44 [GO] 2023―Jun―20 High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection Mizuki Fujisawa, Yu Adachi, Taishi Onodera, Nozomi Shiwa, Naoko Iwata-Yoshikawa, Noriyo Nagata, et al. (+3)
45 [GO] 2023―May―18 Unwinding mechanism of SARS-CoV helicase (nsp13) in the presence of Ca2+, elucidated by biochemical and single-molecular studies Jeongmin Yu, Hyeryeon Im, Gwangrog Lee
46 [GO] 2023―May―02 SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate Christopher A. Beaudoin, Emmanouela Petsolari, Samir W. Hamaia, Sharif Hala, Fadwa S. Alofi, Arun P. Pandurangan, et al. (+4)
47 [GO] 2023―Apr―18 Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma produce soluble factors to suppress SARS-CoV-2 replication Hiroshi Ishii, Kenta Jounai, Ryohei Tsuji, Konomi Ohshio, Daiki Kaneda, Midori Okazaki, et al. (+3)
48 [GO] 2023―Apr―05 Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2 Xiaoyu Chu, Xinyu Ding, Yixuan Yang, Yuchi Lu, Tinghan Li, Yan Gao, et al. (+12)
49 [GO] 2023―Mar―23 Platelet αIIbβ3 integrin binds to SARS-CoV-2 spike protein of alpha strain but not wild type and omicron strains Koyu Ito, Kota Goto, Ryutaro Shirakawa, Hisanori Horiuchi, Kouetsu Ogasawara
50 [GO] 2023―Jan―19 Evaluation of a biotin-based surrogate virus neutralization test for detecting postvaccination antibodies against SARS-CoV-2 variants in sera Min-Ju Ahn, Jung-Ah Kang, Su Min Hong, Kyu-Sun Lee, Dong Ho Kim, Daesub Song, Dae Gwin Jeong
51 [GO] 2023―Jan―14 Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally Sho Kawashima, Yuki Matsui, Takumi Adachi, Yuji Morikawa, Kae Inoue, Shiori Takebayashi, et al. (+4)
52 [GO] 2022―Dec―05 Spike protein receptor-binding domains from SARS-CoV-2 variants of interest bind human ACE2 more tightly than the prototype spike protein Jermilia Charles, Nathan McCann, Victoria A. Ploplis, Francis J. Castellino
53 [GO] 2022―Sep―25 SARS-CoV-2-induced hypomethylation of the ferritin heavy chain (FTH1) gene underlies serum hyperferritinemia in severe COVID-19 patients Jibran Sualeh Muhammad, Gehad ElGhazali, Jasmin Shafarin, Mohammad G. Mohammad, Ameera Abu-Qiyas, Mawieh Hamad
54 [GO] 2022―Sep―07 Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes Aditya K. Padhi, Timir Tripathi
55 [GO] 2022―Aug―14 Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10 Huilin Zhao, Jin Liu, Lei He, Lichuan Zhang, Rilei Yu, Congmin Kang
56 [GO] 2022―Aug―04 SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells Ji-Young Choi, Jung Hyun Park, Chulman Jo, Kyung-Chang Kim, Young Ho Koh
57 [GO] 2022―Aug―02 ATP enhances the error-prone ribonucleotide incorporation by the SARS-CoV-2 RNA polymerase Yasin Pourfarjam, Zhijun Ma, In-Kwon Kim
58 [GO] 2022―Jul―08 Immunization with 674-685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice Olena Lykhmus, Olena Kalashnyk, Lyudmyla Koval, Olga Krynina, Serhiy Komisarenko, Maryna Skok
59 [GO] 2022―Jun―23 SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors Pushpendra Mani Mishra, Farhan Anjum, Vladimir N. Uversky, Chayan Kanti Nandi
60 [GO] 2022―Jun―21 Diabetic Covid-19 severity: Impaired glucose tolerance and pathologic bone loss Jyotirmaya Behera, Jessica Ison, Michael J. Voor, Suresh C. Tyagi, Neetu Tyagi
61 [GO] 2022―May―25 Corrigendum to “Biochemical characterization of SARS-CoV-2 nucleocapsid protein” Weihong Zeng, Guangfeng Liu, Huan Ma, Dan Zhao, Yunru Yang, Muziying Liu, et al. (+10)
62 [GO] 2022―May―13 Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease Wei Wei, Ni Kong, Ming-Zhen Liu, Ting Han, Jun-Feng Xu, Chong Liu
63 [GO] 2022―May―02 A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant) Hirotaka Minagawa, Hirofumi Sawa, Tomoko Fujita, Shintaro Kato, Asumi Inaguma, Miwako Hirose, et al. (+7)
64 [GO] 2022―Apr―22 Crystal structure of SARS-CoV 3C-like protease with baicalein Jingwen Feng, Dongyang Li, Jin Zhang, Xiushan Yin, Jian Li
65 [GO] 2022―Apr―20 Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes Kazuhiro Sugamoto, Yuri L. Tanaka, Akatsuki Saito, Yoh Goto, Takayuki Nakayama, Tamaki Okabayashi, et al. (+2)
66 [GO] 2022―Mar―23 High-resolution melting analysis after nested PCR for the detection of SARS-CoV-2 spike protein G339D and D796Y variations Hiroshi Miyoshi, Ryu Ichinohe, Takuro Koshikawa
67 [GO] 2022―Mar―18 Structural insights revealed by crystal structure of B38-CAP, an isoenzyme of carboxypeptidase ACE2, the receptor of SARS-CoV-2 Peiyuan Liu, Yanfeng Zhang, Zibin Li, Jianwen Huang, Tao Wang, Cheng Chen
68 [GO] 2022―Mar―16 Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19 Davoud Ghazanfari, Maria Cecilia Courreges, Lydia Belinski, Stephen C. Bergmeier, Kelly D. McCall, Douglas J. Goetz
69 [GO] 2022―Mar―14 Harnessing coronavirus spike proteins' binding affinity to ACE2 receptor through A novel Baculovirus surface display system Lin Wang, Lixia Zhao, Yu Li, Peixiang Ma, Roger D. Kornberg, Yan Nie
70 [GO] 2022―Mar―10 Discovery of 4′-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor Qianqian Wu, Shiqiang Yan, Yujie Wang, Maotian Li, Yibei Xiao, Yingxia Li
71 [GO] 2022―Feb―23 The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity Kun Yue, Bin Yao, Yingchao Shi, Yang Yang, Zhaohui Qian, Yali Ci, Lei Shi
72 [GO] 2022―Jan―29 The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione Mana Murae, Yoshimi Shimizu, Yuichiro Yamamoto, Asuka Kobayashi, Masumi Houri, Tetsuya Inoue, et al. (+13)
73 [GO] 2022―Jan―15 How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17 Eamonn F. Healy
74 [GO] 2021―Dec―30 Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2 Junjie Chen, Yaya Zhang, Dequan Zeng, Bingchang Zhang, Xiaohong Ye, Zhiping Zeng, et al. (+3)
75 [GO] 2021―Dec―24 Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor Cecylia S. Lupala, Yongjin Ye, Hong Chen, Xiao-Dong Su, Haiguang Liu
76 [GO] 2021―Nov―22 Emerging mutation patterns in SARS-CoV-2 variants David A. Ostrov, Glenn W. Knox
77 [GO] 2021―Nov―20 NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells Kei Makiyama, Masaharu Hazawa, Akiko Kobayashi, Keesiang Lim, Dominic Chih-Cheng Voon, Richard Wong
78 [GO] 2021―Oct―21 Linking COVID-19 and Parkinson's disease: Targeting the role of Vitamin-D Tapan Behl, Sachin Kumar, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Sridevi Chirgurupati, et al. (+4)
79 [GO] 2021―Sep―23 SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells Luping Zheng, Yingxin Ma, Minghai Chen, Guoqiang Wu, Chuang Yan, Xian-En Zhang
80 [GO] 2021―Sep―15 SARS-CoV-2 triggers DNA damage response in Vero E6 cells Joshua Victor, Jamie Deutsch, Annalis Whitaker, Erica N. Lamkin, Anthony March, Pei Zhou, et al. (+2)
81 [GO] 2021―Sep―13 The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2 Dong-Kyun Ryu, Bobin Kang, Hanmi Noh, Sun-Je Woo, Min-Ho Lee, Patricia M. Nuijten, et al. (+16)
82 [GO] 2021―Sep―08 Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells Michihito Sasaki, Mai Kishimoto, Yukari Itakura, Koshiro Tabata, Kittiya Intaruck, Kentaro Uemura, et al. (+6)
83 [GO] 2021―Aug―23 Strong alkaline electrolyzed water efficiently inactivates SARS-CoV-2, other viruses, and Gram-negative bacteria Youichi Suzuki, Takayuki Hishiki, Akino Emi, Shoichi Sakaguchi, Ronko Itamura, Rain Yamamoto, et al. (+5)
84 [GO] 2021―Aug―15 A model for COVID-19-induced dysregulation of ACE2 shedding by ADAM17 Eamonn F. Healy, Marko Lilic
85 [GO] 2021―Aug―15 Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion Prabin Baral, Nisha Bhattarai, Md Lokman Hossen, Vitalii Stebliankin, Bernard S. Gerstman, Giri Narasimhan, Prem P. Chapagain
86 [GO] 2021―Jul―20 A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding Yingyi Long, Shuyi Song, Feiyang Luo, Xiaojian Han, Chao Hu, Yingming Wang, et al. (+6)
87 [GO] 2021―Jul―16 Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight Feroza Begum, Amit Kumar Srivastava, Upasana Ray
88 [GO] 2021―Jul―13 Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro Mami Oba, Wen Rongduo, Akatsuki Saito, Tamaki Okabayashi, Tomoko Yokota, Junko Yasuoka, et al. (+5)
89 [GO] 2021―Jul―02 Analysis of SARS-CoV-2 nucleocapsid phosphoprotein N variations in the binding site to human 14-3-3 proteins Samanta Del Veliz, Lautaro Rivera, Diego M. Bustos, Marina Uhart
90 [GO] 2021―Jun―10 Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method Kevin Maafu Juma, Teisuke Takita, Kenji Ito, Masaya Yamagata, Shihomi Akagi, Emi Arikawa, et al. (+6)
91 [GO] 2021―Jun―07 Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant Dong-Kyun Ryu, Rina Song, Minsoo Kim, Young-Il Kim, Cheolmin Kim, Jong-In Kim, et al. (+10)
92 [GO] 2021―Jun―05 Analysis of the molecular mechanism of SARS-CoV-2 antibodies Dongfu Jin, Jing Wei, Jian Sun
93 [GO] 2021―May―29 Quantitative circular flow immunoassays with trained object recognition to detect antibodies to SARS-CoV-2 membrane glycoprotein Ryan Yuki Huang, Deron Raymond Herr
94 [GO] 2021―May―26 Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant Shinya Ohki, Tomohiro Imamura, Yasuki Higashimura, Kenji Matsumoto, Masashi Mori
95 [GO] 2021―May―21 Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective Ibrahim M. Ibrahim, Abdo A. Elfiky, Alaa M. Elgohary
96 [GO] 2021―May―11 SARS-Cov-2 spike protein fragment 674-685 protects mitochondria from releasing cytochrome c in response to apoptogenic influence Olena Kalashnyk, Olena Lykhmus, Mykhailo Izmailov, Lyudmyla Koval, Serhiy Komisarenko, Maryna Skok
97 [GO] 2021―Apr―21 Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197 Bellone Maria Laura, Puglisi Andrea, Dal Piaz Fabrizio, Hochkoeppler Alejandro
98 [GO] 2021―Apr―08 In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5 Dai Hatakeyama, Takeshi Masuda, Ryosuke Miki, Sumio Ohtsuki, Takashi Kuzuhara
99 [GO] 2021―Mar―26 ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model Koen Vandyck, Rana Abdelnabi, Kusum Gupta, Dirk Jochmans, Andreas Jekle, Jerome Deval, et al. (+18)
100 [GO] 2021―Mar―26 Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation Aditya K. Padhi, Timir Tripathi
101 [GO] 2021―Mar―24 SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration Danish Idress, Vijay Kumar
102 [GO] 2021―Mar―19 A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs Yue Zhang, Guanglin Niu, Tatiana Flisikowska, Angelika Schnieke, Krzysztof Flisikowski
103 [GO] 2021―Mar―15 A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2 Robert L. Kruse, Yuting Huang, Heather Smetana, Eric A. Gehrie, Tim K. Amukele, Aaron A.R. Tobian, et al. (+2)
104 [GO] 2021―Feb―26 SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring Filipe Pereira
105 [GO] 2021―Feb―15 Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity Sandipan Chakraborty
106 [GO] 2021―Feb―13 Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand Kannikar Intawong, Debra Olson, Suwat Chariyalertsak
107 [GO] 2021―Feb―10 EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro Minsu Jang, Rackhyun Park, Yea-In Park, Yeo-Eun Cha, Ayane Yamamoto, Jin I. Lee, Junsoo Park
108 [GO] 2021―Feb―04 H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine Eduardo Alfredo Adami, Stefanni Liliane Chavez Rico, Milena Apetito Akamatsu, Cosue Miyaki, Isaías Raw, Dourival de Oliveira, et al. (+8)
109 [GO] 2021―Jan―29 5-amino levulinic acid inhibits SARS-CoV-2 infection Yasuteru Sakurai, Mya Myat Ngwe Tun, Yohei Kurosaki, Takaya Sakura, Daniel Ken Inaoka, Kiyotaka Fujine, et al. (+3)
110 [GO] 2021―Jan―22 The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients Veronique A.J. Smits, Esperanza Hernández-Carralero, María Cristina Paz-Cabrera, Elisa Cabrera, Yeray Hernández-Reyes, Juan Ramón Hernández-Fernaud, et al. (+4)
111 [GO] 2021―Jan―15 ATP biphasically modulates LLPS of SARS-CoV-2 nucleocapsid protein and specifically binds its RNA-binding domain Mei Dang, Yifan Li, Jianxing Song
112 [GO] 2021―Jan―15 RNA sequence and ligand binding alter conformational profile of SARS-CoV-2 stem loop II motif Ali H. Aldhumani, Md Ismail Hossain, Emily A. Fairchild, Hannah Boesger, Emily C. Marino, Mason Myers, Jennifer V. Hines
113 [GO] 2021―Jan―10 Nonlinear adaptive control of COVID-19 with media campaigns and treatment Boqiang Cao, Ting Kang
114 [GO] 2021―Jan―08 The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy Yasir Mohamud, Yuan Chao Xue, Huitao Liu, Chen Seng Ng, Amirhossein Bahreyni, Eric Jan, Honglin Luo
115 [GO] 2021―Jan―06 The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease Wei-Chung Chiou, Jui-Chieh Chen, Jinn-Moon Yang, Lih-Hwa Hwang, Yi-Shuan Lyu, Hsin-Yi Yang, Cheng Huang
116 [GO] 2021―Jan―01 Pathogenesis of COVID-19 and the quality control of nucleic acid detection Xiao-Dong Mao, Taiping Li, Zhirong Xu, Kangsheng Liu
117 [GO] 2020―Dec―26 In silico study of the potential interactions of 4′-acetamidechalcones with protein targets in SARS-CoV-2 Francisco Wagner Q. Almeida-Neto, Maria Geysillene Castro Matos, Emanuelle M. Marinho, Márcia M. Marinho, Ramon R.P.P.B. de Menezes, Tiago L. Sampaio, et al. (+6)
118 [GO] 2020―Dec―24 Comprehensive analysis of COVID-19 during pregnancy Kathryn M. Moore, Mehul S. Suthar
119 [GO] 2020―Dec―13 Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex Koki Kato, Dini Kurnia Ikliptikawati, Akiko Kobayashi, Hiroya Kondo, Keesiang Lim, Masaharu Hazawa, Richard W. Wong
120 [GO] 2020―Dec―09 Range of reproduction number estimates for COVID-19 spread Damiano Pasetto, Joseph C. Lemaitre, Enrico Bertuzzo, Marino Gatto, Andrea Rinaldo
121 [GO] 2020―Dec―05 A perspective on early detection systems models for COVID-19 spreading Chiara Vianello, Fernanda Strozzi, Paolo Mocellin, Elisa Cimetta, Bruno Fabiano, Flavio Manenti, et al. (+2)
122 [GO] 2020―Dec―03 Identification of antiviral antihistamines for COVID-19 repurposing Leah R. Reznikov, Michael H. Norris, Rohit Vashisht, Andrew P. Bluhm, Danmeng Li, Yan-Shin J. Liao, et al. (+3)
123 [GO] 2020―Nov―28 Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors Daoqun Li, Junwen Luan, Leiliang Zhang
124 [GO] 2020―Nov―28 The biogenesis of SARS-CoV-2 spike glycoprotein: Multiple targets for host-directed antiviral therapy Silvia Santopolo, Anna Riccio, M. Gabriella Santoro
125 [GO] 2020―Nov―28 Structural stability of SARS-CoV-2 virus like particles degrades with temperature A. Sharma, B. Preece, H. Swann, X. Fan, R.J. McKenney, K.M. Ori-McKenney, et al. (+2)
126 [GO] 2020―Nov―28 Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature Erica Bacca, Margherita Digaetano, Marianna Meschiari, Erica Franceschini, Marianna Menozzi, Gianluca Cuomo, Cristina Mussini
127 [GO] 2020―Nov―28 Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity Sandipan Chakraborty
128 [GO] 2020―Nov―21 The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2 Zhenming Jin, Haofeng Wang, Yinkai Duan, Haitao Yang
129 [GO] 2020―Nov―20 Remdesivir: From Ebola to COVID-19 M. Gabriella Santoro, Ernesto Carafoli
130 [GO] 2020―Nov―20 Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches Koichi Watashi
131 [GO] 2020―Nov―20 Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics Martin A. Walsh, Jonathan M. Grimes, David I. Stuart
132 [GO] 2020―Nov―20 Dual ELISA using SARS-CoV-2 nucleocapsid protein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation Airi Rump, Robert Risti, Mai-Ly Kristal, Jekaterina Reut, Vitali Syritski, Aivar Lookene, Sirje Ruutel Boudinot
133 [GO] 2020―Nov―17 Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2 Marcelo A. Lima, Mark Skidmore, Farhat Khanim, Alan Richardson
134 [GO] 2020―Nov―17 Vaccine-induced protection in aging adults and pandemic response Theodore Schenkelberg
135 [GO] 2020―Nov―13 A nidovirus perspective on SARS-CoV-2 Anastasia A. Gulyaeva, Alexander E. Gorbalenya
136 [GO] 2020―Nov―13 Functional importance of the D614G mutation in the SARS-CoV-2 spike protein Cody B. Jackson, Lizhou Zhang, Michael Farzan, Hyeryun Choe
137 [GO] 2020―Nov―11 Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand Kannikar Intawong, Debra Olson, Suwat Chariyalertsak
138 [GO] 2020―Nov―07 T-cell dysregulation in COVID-19 Bahire Kalfaoglu, José Almeida-Santos, Chanidapa Adele Tye, Yorifumi Satou, Masahiro Ono
139 [GO] 2020―Nov―07 Proactive and blended approach for COVID-19 control in Taiwan Hao-Yuan Cheng, Angela Song-En Huang
140 [GO] 2020―Nov―07 Biochemical and Biophysical Research Communications History of the COVID-19 pandemic: Origin, explosion, worldwide spreading Sara Platto, Yanqing Wang, Jinfeng Zhou, Ernesto Carafoli
141 [GO] 2020―Nov―07 Evolution patterns of SARS-CoV-2: Snapshot on its genome variants Marta Giovanetti, Francesca Benedetti, Giovanni Campisi, Alessandra Ciccozzi, Silvia Fabris, Giancarlo Ceccarelli, et al. (+5)
142 [GO] 2020―Nov―07 Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity Jorge Carrillo, Nuria Izquierdo-Useros, Carlos Ávila-Nieto, Edwards Pradenas, Bonaventura Clotet, Julià Blanco
143 [GO] 2020―Nov―05 Host-directed editing of the SARS-CoV-2 genome Tobias Mourier, Mukhtar Sadykov, Michael J. Carr, Gabriel Gonzalez, William W. Hall, Arnab Pain
144 [GO] 2020―Nov―05 The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design Danielle C. Groves, Sarah L. Rowland-Jones, Adrienn Angyal
145 [GO] 2020―Nov―02 Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19 Dylan C. Sarver, G. William Wong
146 [GO] 2020―Oct―28 Laboratory testing for the diagnosis of COVID-19 Christopher Koon Chi Lai, Wilson Lam
147 [GO] 2020―Oct―26 Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives Cheryl Baxter, Quarraisha Abdool Karim, Salim S. Abdool Karim
148 [GO] 2020―Oct―23 T cell immunity to SARS-CoV-2 following natural infection and vaccination Anthony T. DiPiazza, Barney S. Graham, Tracy J. Ruckwardt
149 [GO] 2020―Oct―21 Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2 Luca Zinzula
150 [GO] 2020―Oct―21 The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2? David A. Jans, Kylie M. Wagstaff
151 [GO] 2020―Oct―16 Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease Sara Platto, Jinfeng Zhou, Yanqing Wang, Huo Wang, Ernesto Carafoli
152 [GO] 2020―Oct―10 Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19 Jacques Fantini, Henri Chahinian, Nouara Yahi
153 [GO] 2020―Oct―10 Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies Meng Yuan, Hejun Liu, Nicholas C. Wu, Ian A. Wilson
154 [GO] 2020―Oct―03 High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2 Luca Zinzula, Jerome Basquin, Stefan Bohn, Florian Beck, Sven Klumpe, Günter Pfeifer, et al. (+4)
155 [GO] 2020―Sep―30 Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection Ernesto Carafoli
156 [GO] 2020―Sep―18 Machine learning methods accurately predict host specificity of coronaviruses based on spike sequences alone Kiril Kuzmin, Ayotomiwa Ezekiel Adeniyi, Arthur Kevin DaSouza, Deuk Lim, Huyen Nguyen, Nuria Ramirez Molina, et al. (+3)
157 [GO] 2020―Sep―14 The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues Jialu Qiao, Weiling Li, Jian Bao, Qian Peng, Dongmei Wen, Jianing Wang, Binlian Sun
158 [GO] 2020―Sep―11 Potent antiviral effect of silver nanoparticles on SARS-CoV-2 Sundararaj S. Jeremiah, Kei Miyakawa, Takeshi Morita, Yutaro Yamaoka, Akihide Ryo
159 [GO] 2020―Sep―04 RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19 Yi Jiang, Wanchao Yin, H. Eric Xu
160 [GO] 2020―Aug―25 Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage Tzu-Hau Shi, Yi-Long Huang, Chiao-Che Chen, Wen-Chieh Pi, Yu-Ling Hsu, Lee-Chiang Lo, et al. (+3)
161 [GO] 2020―Aug―15 Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3 H.Y. Lim Tung, Pierre Limtung
162 [GO] 2020―Jul―21 Establishment and validation of a drug-target microarray for SARS-CoV-2 Peng Chen, Zehua Zeng, Hongwu Du
163 [GO] 2020―Jul―14 Acidic electrolyzed water potently inactivates SARS-CoV-2 depending on the amount of free available chlorine contacting with the virus Yohei Takeda, Hiroshi Uchiumi, Sachiko Matsuda, Haruko Ogawa
164 [GO] 2020―Jun―20 SARS-CoV-2 E protein is a potential ion channel that can Be inhibited by Gliclazide and Memantine Prabhat Pratap Singh Tomar, Isaiah T. Arkin
165 [GO] 2020―Jun―16 Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein Haiyang Zhang, Jialu Tu, Chulei Cao, Ting Yang, Liangcai Gao
166 [GO] 2020―Jun―09 Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system Ryosuke Fujita, Masato Hino, Takeru Ebihara, Takumi Nagasato, Akitsu Masuda, Jae Man Lee, et al. (+8)
167 [GO] 2020―Jun―08 Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents Lalu Muhammad Irham, Wan-Hsuan Chou, Marcus J. Calkins, Wirawan Adikusuma, Shie-Liang Hsieh, Wei-Chiao Chang
168 [GO] 2020―May―29 Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke Choi Ji-Young, Lee Hye-Kyung, Park Jung Hyun, Cho Sun-Jung, Kwon Munjin, Jo Chulman, Koh Young Ho
169 [GO] 2020―May―14 Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism Houcemeddine Othman, Zied Bouslama, Jean-Tristan Brandenburg, Jorge da Rocha, Yosr Hamdi, Kais Ghedira, et al. (+2)
170 [GO] 2020―May―06 Stability of RNA sequences derived from the coronavirus genome in human cells Hiroyasu Wakida, Kentaro Kawata, Yuta Yamaji, Emi Hattori, Takaho Tsuchiya, Youichiro Wada, et al. (+2)
171 [GO] 2020―Apr―30 Biochemical characterization of SARS-CoV-2 nucleocapsid protein Weihong Zeng, Guangfeng Liu, Huan Ma, Dan Zhao, Yunru Yang, Muziying Liu, et al. (+10)
172 [GO] 2020―Apr―09 A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization Pietro Bongini, Alfonso Trezza, Monica Bianchini, Ottavia Spiga, Neri Niccolai
173 [GO] 2020―Mar―19 Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses Furong Qi, Shen Qian, Shuye Zhang, Zheng Zhang
174 [GO] 2020―Mar―19 Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection Junwen Luan, Yue Lu, Xiaolu Jin, Leiliang Zhang
175 [GO] 2020―Feb―17 Structure analysis of the receptor binding of 2019-nCoV Yun Chen, Yao Guo, Yihang Pan, Zhizhuang Joe Zhao
 [1] 

175 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec